Literature DB >> 10852134

Role of self-major histocompatibility complex/peptide ligands in selection and maintenance of a diverse T cell repertoire.

C D Surh1, B Ernst, D S Lee, W Dummer, E LeRoy.   

Abstract

Positive selection has long been thought to be a devise for producing a repertoire of T cells that can efficiently recognize foreign peptides in the context of self-major histocompatibility complex (MHC) molecules. However, in the light of recent evidence that long-term survival of mature T cells requires continuous contact with self-MHC molecules, the possibility for an additional role for positive selection has emerged: to generate a repertoire of T cells that can be maintained in the periphery through contact with self-MHC/peptide ligands. In support of this idea, our recent work suggests that positive selection is highly peptide specific and, more important, that mature T cells require extrathymic contact with the same MHC/peptide ligands that initially induced positive selection in the thymus in order for prolonged survival and to undergo homeostatic proliferation in response to T cell deficiency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852134     DOI: 10.1385/IR:21:2-3:331

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  43 in total

1.  Thymic selection by a single MHC/peptide ligand: autoreactive T cells are low-affinity cells.

Authors:  D S Lee; C Ahn; B Ernst; J Sprent; C D Surh
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

2.  MHC class I is required for peripheral accumulation of CD8+ thymic emigrants.

Authors:  D Nesić; S Vukmanović
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

Review 3.  Restoration of T-cell homeostasis after T-cell depletion.

Authors:  C L Mackall; F T Hakim; R E Gress
Journal:  Semin Immunol       Date:  1997-12       Impact factor: 11.130

4.  Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses.

Authors:  R Rooke; C Waltzinger; C Benoist; D Mathis
Journal:  Immunity       Date:  1997-07       Impact factor: 31.745

5.  T cells can be activated by peptides that are unrelated in sequence to their selecting peptide.

Authors:  L Ignatowicz; W Rees; R Pacholczyk; H Ignatowicz; E Kushnir; J Kappler; P Marrack
Journal:  Immunity       Date:  1997-08       Impact factor: 31.745

6.  Selection of a broad repertoire of CD4+ T cells in H-2Ma0/0 mice.

Authors:  S Tourne; T Miyazaki; A Oxenius; L Klein; T Fehr; B Kyewski; C Benoist; D Mathis
Journal:  Immunity       Date:  1997-08       Impact factor: 31.745

Review 7.  Positive selection of thymocytes.

Authors:  S C Jameson; K A Hogquist; M J Bevan
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

8.  Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo.

Authors:  B Rocha; N Dautigny; P Pereira
Journal:  Eur J Immunol       Date:  1989-05       Impact factor: 5.532

9.  Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules.

Authors:  J Kirberg; A Berns; H von Boehmer
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

10.  Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells.

Authors:  T Brocker
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

View more
  2 in total

Review 1.  Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT).

Authors:  Andrea I Loewendorf; Marie Csete; Alan Flake
Journal:  Front Pharmacol       Date:  2015-01-06       Impact factor: 5.810

2.  Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells?

Authors:  Isabelle Grandjean; Livine Duban; Elizabeth A Bonney; Erwan Corcuff; James P Di Santo; Polly Matzinger; Olivier Lantz
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.